Randomized phase 3 study of elotuzumab for relapsed or...

Blood Cancer Journal 2017 / 3 Vol. 7; Iss. 3

Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysis

Suzuki, K, Sunami, K, Ohashi, K, Iida, S, Mori, T, Handa, H, Matsue, K, Miyoshi, M, Bleickardt, E, Matsumoto, M, Taniwaki, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2017.18
Date:
March, 2017
File:
PDF, 167 KB
english, 2017
Conversion to is in progress
Conversion to is failed